A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients

被引：14
作者：
Carow K. [1 ]
Read C. [2 ]
Häfner N. [1 ]
Runnebaum I.B. [1 ]
Corner A. [2 ]
Dürst M. [1 ]
机构：
[1] Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin, Universitätsklinikum Jena, Am Klinikum 1, Jena
[2] RainDance Technologies, 749 Middlesex Turnpike, Billerica, 01821, MA
来源：
BMC Research Notes | / 10卷 / 1期
关键词：
Cervical cancer; Digital PCR; HPV mRNA; Molecular marker; Quantitative PCR; Recurrence; Sentinel lymph node;
D O I：
10.1186/s13104-017-2846-8
中图分类号：
学科分类号：
摘要：
Background: Qualitative analyses showed that the presence of HPV mRNA in sentinel lymph nodes of cervical cancer patients with pN0 status is associated with significantly decreased recurrence free survival. To further address the clinical potential of the strategy and to define prognostic threshold levels it is necessary to use a quantitative assay. Here, we compare two methods of quantification: digital PCR and standard quantitative PCR. Methods: Serial dilutions of 5 ng-5 pg RNA (≈ 500-0.5 cells) of the cervical cancer cell line SiHa were prepared in 5 μg RNA of the HPV-negative human keratinocyte cell line HaCaT. Clinical samples consisted of 10 sentinel lymph nodes with varying HPV transcript levels. Reverse transcription of total RNA (5 μg RNA each) was performed in 100 μl and cDNA aliquots were analyzed by qPCR and dPCR. Digital PCR was run in the RainDrop® Digital PCR system (RainDance Technologies) using a probe-based detection of HPV E6/E7 cDNA PCR products with 11 μl template. qPCR was done using a Rotor Gene Q 5plex HRM (Qiagen) amplifying HPV E6/E7 cDNA in a SYBR Green format with 1 μl template. Results: For the analysis of both, clinical samples and serial dilution samples, dPCR and qPCR showed comparable sensitivity. With regard to reproducibility, both methods differed considerably, especially for low template samples. Here, we found with qPCR a mean variation coefficient of 126% whereas dPCR enabled a significantly lower mean variation coefficient of 40% (p = 0.01). Generally, we saw with dPCR a substantial reduction of subsampling errors, which most likely reflects the large cDNA amounts available for analysis. Conclusions: Compared to real-time PCR, dPCR shows higher reliability. Thus, our HPV mRNA dPCR assay holds promise for the clinical evaluation of occult tumor cells in histologically tumor-free lymph nodes in future studies. © 2017 The Author(s).
引用
收藏
相关论文
共 13 条
  • [1] Delgado G., Bundy B.N., Fowler W.C., Stehman F.B., Sevin B., Creasman W.T., Major F., DiSaia P., Zaino R., A prospective surgical pathological study of stage i squamous carcinoma of the cervix: A Gynecologic Oncology Group Study, Gynecol Oncol, 35, 3, pp. 314-320, (1989)
  • [2] Look K.Y., Brunetto V.L., Clarke-Pearson D.L., Averette H.E., Major F.J., Alvarez R.D., Homesley H.D., Zaino R.J., An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: A Gynecologic Oncology Group study, Gynecol Oncol, 63, 3, pp. 304-311, (1996)
  • [3] Durst M., Hoyer H., Altgassen C., Greinke C., Hafner N., Fishta A., Gajda M., Mahnert U., Hillemanns P., Dimpfl T., Et al., Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status, Oncotarget, 6, 26, pp. 23015-23025, (2015)
  • [4] Wittwer C.T., Herrmann M.G., Moss A.A., Rasmussen R.P., Continuous fluorescence monitoring of rapid cycle DNA amplification, Biotechniques, 22, 1, pp. 130-131, (1997)
  • [5] Vogelstein B., Kinzler K.W., Digital PCR, Proc Natl Acad Sci USA, 96, 16, pp. 9236-9241, (1999)
  • [6] Hafner N., Gajda M., Altgassen C., Hertel H., Greinke C., Hillemanns P., Schneider A., Durst M., HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR, Int J Cancer, 120, 9, pp. 1842-1846, (2007)
  • [7] Strain M.C., Lada S.M., Luong T., Rought S.E., Gianella S., Terry V.H., Spina C.A., Woelk C.H., Richman D.D., Highly precise measurement of HIV DNA by droplet digital PCR, PLoS ONE, 8, 4, (2013)
  • [8] Hindson C.M., Chevillet J.R., Briggs H.A., Gallichotte E.N., Ruf I.K., Hindson B.J., Vessella R.L., Tewari M., Absolute quantification by droplet digital PCR versus analog real-time PCR, Nat Methods, 10, 10, pp. 1003-1005, (2013)
  • [9] Taly V., Pekin D., El Abed A., Laurent-Puig P., Detecting biomarkers with microdroplet technology, Trends Mol Med, 18, 7, pp. 405-416, (2012)
  • [10] Sedlak R.H., Cook L., Cheng A., Magaret A., Jerome K.R., Clinical utility of droplet digital PCR for human cytomegalovirus, J Clin Microbiol, 52, 8, pp. 2844-2848, (2014)
12